BR0010231A - Derivados de halo de 9a-n-(n'-larilcarbamoil)- e 9a-n-(n'l- ariltiocarbamoil)-9-desoxo-9a-aza-9a-homoeritromici na a - Google Patents
Derivados de halo de 9a-n-(n'-larilcarbamoil)- e 9a-n-(n'l- ariltiocarbamoil)-9-desoxo-9a-aza-9a-homoeritromici na aInfo
- Publication number
- BR0010231A BR0010231A BR0010231-8A BR0010231A BR0010231A BR 0010231 A BR0010231 A BR 0010231A BR 0010231 A BR0010231 A BR 0010231A BR 0010231 A BR0010231 A BR 0010231A
- Authority
- BR
- Brazil
- Prior art keywords
- deoxo
- meaning
- aza
- halo
- group
- Prior art date
Links
- 125000001475 halogen functional group Chemical group 0.000 title abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 125000004438 haloalkoxy group Chemical group 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Patente de Invenção: "DERIVADOS DE HALO DE 9a-N-(N'-ARILCARBAMOIL)- E 9a-N-(N'-ARILTIOCARBAMOIL)-9-DESOXO-9a-AZA-9a-HOMOERI TROMICINA A". A invenção refere-se a derivados de halo de 9a-N-(N'-arilcarbamoil)- e 9a-N-(N'-ariltiocarbamoil)-9-desoxo-9a-aza-9a-homoeritromicina A de fórmula geral (I) onde R tem o significado de um grupo arila substituído de fórmula (II) onde os substituintes a, b, c, d e e são os mesmos ou diferentes e pelo menos um deles tem o significado de halo, um grupo (C~ 1~-C~ 6~)haloalquila ou um grupo (C~ 1~-C~ 6~)haloalcóxi considerando que os substituintes restantes têm o significado de hidrogênio, halo, um grupo (C~ 1~-C~ 6~)alquila ou um grupo (C~ 1~-C~ 6~)alcóxi, e X tem o significado de oxigênio ou enxofre, e sais de adição farmaceuticamente aceitáveis dos mesmos com ácidos inorgânicos ou orgânicos, a um processo para sua preparação, a um processo para a preparação de composições farmacêuticas que os compreendem e ao uso dessas composições farmacêuticas para o tratamento ou prevenção de infecções bacterianas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HR990130A HRP990130B1 (en) | 1999-05-03 | 1999-05-03 | HALOGEN DERIVATIVES 9a-N-(N'-ARYLCARBAMOYL)- AND 9a-N-(N'-ARYLTHIOCARBAMOYL)-9-DEOXO-9a-AZA-9a OF HOMOERYTHROMYCIN A |
PCT/HR2000/000013 WO2000066603A1 (en) | 1999-05-03 | 2000-05-02 | Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0010231A true BR0010231A (pt) | 2002-02-19 |
Family
ID=10946916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0010231-8A BR0010231A (pt) | 1999-05-03 | 2000-05-02 | Derivados de halo de 9a-n-(n'-larilcarbamoil)- e 9a-n-(n'l- ariltiocarbamoil)-9-desoxo-9a-aza-9a-homoeritromici na a |
Country Status (33)
Country | Link |
---|---|
US (1) | US6872707B1 (pt) |
EP (1) | EP1175429B1 (pt) |
JP (1) | JP2002543213A (pt) |
KR (1) | KR100714740B1 (pt) |
CN (1) | CN1140535C (pt) |
AT (1) | ATE244258T1 (pt) |
AU (1) | AU767681B2 (pt) |
BG (1) | BG106173A (pt) |
BR (1) | BR0010231A (pt) |
CA (1) | CA2372977A1 (pt) |
CZ (1) | CZ20013913A3 (pt) |
DE (1) | DE60003671T2 (pt) |
DK (1) | DK1175429T3 (pt) |
EA (1) | EA005214B1 (pt) |
EE (1) | EE05007B1 (pt) |
ES (1) | ES2202107T3 (pt) |
GE (1) | GEP20032928B (pt) |
HK (1) | HK1045522B (pt) |
HR (1) | HRP990130B1 (pt) |
HU (1) | HUP0201146A3 (pt) |
IL (2) | IL145986A0 (pt) |
IS (1) | IS6115A (pt) |
MX (1) | MXPA01011038A (pt) |
NO (1) | NO320138B1 (pt) |
NZ (1) | NZ515278A (pt) |
PL (1) | PL351402A1 (pt) |
PT (1) | PT1175429E (pt) |
SI (1) | SI1175429T1 (pt) |
SK (1) | SK284513B6 (pt) |
TR (1) | TR200103143T2 (pt) |
UA (1) | UA71962C2 (pt) |
WO (1) | WO2000066603A1 (pt) |
ZA (1) | ZA200108484B (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HRP20010146B1 (en) * | 2001-02-28 | 2005-10-31 | Pliva D.D. | 9a-N-(N'-(PHENYLSULFONYL)CARBAMOYL) DERIVATIVES OF 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMYCIN A AND OF 5-O-DESOSAMINYL-9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHRONOLIDE A |
HRP20020885B1 (en) * | 2002-11-11 | 2007-05-31 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | SUBSTITUTED 9a-N-{N'-[4-(SULFONYL)PHENYLCARBAMOYL]}DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHROMYCIN A AND 5-O-DESOZAMINYL-9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHRONOLIDE A |
HRP20020886A2 (en) * | 2002-11-11 | 2005-06-30 | PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. | SUBSTITUTED 9a-N-[N'-(BENZENSULFONYL)CARBAMOYL-γ-AMINOPROPYL) AND 9a-N(N' -(?-CYANOETHIL)-N' -(b |
HRP20020991A2 (en) * | 2002-12-12 | 2005-02-28 | Pliva-Istra�iva�ki institut d.o.o. | N"-Substituted 9a-N-(N'-carbamoyl-Gamma-aminopropyl), 9a-N-(N'? -thiocarbamoyl-Gamma-aminopropyl), 9a-N-(N'-((Beta-cyanoethyl)-N'-carbamoyl-Gamma? -aminopropyl) and 9a-N-(N'-(Beta-cyanoethyl)-N'-thiocarbamoyl-Gamma? -aminopropyl) derivatives of 9-de |
HRP20030381B1 (en) * | 2003-05-14 | 2007-05-31 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | 3-DECLADINOZYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICYNE A |
ATE429921T1 (de) * | 2005-01-14 | 2009-05-15 | Glaxosmithkline Zagreb | 9a-carbamoyl- und thiocarbamoylazalide mit antimalariawirkung |
MX2010002932A (es) * | 2007-09-17 | 2010-05-27 | Enanta Pharm Inc | Macrolidos de biarilo con puente en 6, 11. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI7910768A8 (en) * | 1979-04-02 | 1996-06-30 | Pliva Pharm & Chem Works | Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives |
WO1992006991A1 (fr) * | 1990-10-15 | 1992-04-30 | Taisho Pharmaceutical Co., Ltd. | Erythromycine modifiee en 2' ou derive de cette substance |
HRP931480B1 (en) * | 1993-12-08 | 1997-08-31 | Sour Pliva | 9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A |
-
1999
- 1999-05-03 HR HR990130A patent/HRP990130B1/xx not_active IP Right Cessation
-
2000
- 2000-02-05 UA UA2001118221A patent/UA71962C2/uk unknown
- 2000-05-02 KR KR1020017014046A patent/KR100714740B1/ko not_active IP Right Cessation
- 2000-05-02 DK DK00920940T patent/DK1175429T3/da active
- 2000-05-02 HU HU0201146A patent/HUP0201146A3/hu unknown
- 2000-05-02 CA CA002372977A patent/CA2372977A1/en not_active Abandoned
- 2000-05-02 EA EA200101170A patent/EA005214B1/ru not_active IP Right Cessation
- 2000-05-02 DE DE60003671T patent/DE60003671T2/de not_active Expired - Fee Related
- 2000-05-02 PL PL00351402A patent/PL351402A1/xx unknown
- 2000-05-02 CN CNB008071500A patent/CN1140535C/zh not_active Expired - Fee Related
- 2000-05-02 SK SK1570-2001A patent/SK284513B6/sk not_active IP Right Cessation
- 2000-05-02 IL IL14598600A patent/IL145986A0/xx active IP Right Grant
- 2000-05-02 MX MXPA01011038A patent/MXPA01011038A/es active IP Right Grant
- 2000-05-02 JP JP2000615632A patent/JP2002543213A/ja active Pending
- 2000-05-02 PT PT00920940T patent/PT1175429E/pt unknown
- 2000-05-02 EE EEP200100582A patent/EE05007B1/xx not_active IP Right Cessation
- 2000-05-02 TR TR2001/03143T patent/TR200103143T2/xx unknown
- 2000-05-02 WO PCT/HR2000/000013 patent/WO2000066603A1/en active IP Right Grant
- 2000-05-02 NZ NZ515278A patent/NZ515278A/xx unknown
- 2000-05-02 ES ES00920940T patent/ES2202107T3/es not_active Expired - Lifetime
- 2000-05-02 AU AU41350/00A patent/AU767681B2/en not_active Ceased
- 2000-05-02 US US09/959,662 patent/US6872707B1/en not_active Expired - Fee Related
- 2000-05-02 AT AT00920940T patent/ATE244258T1/de not_active IP Right Cessation
- 2000-05-02 BR BR0010231-8A patent/BR0010231A/pt not_active IP Right Cessation
- 2000-05-02 GE GEAP20006227A patent/GEP20032928B/en unknown
- 2000-05-02 CZ CZ20013913A patent/CZ20013913A3/cs unknown
- 2000-05-02 SI SI200030188T patent/SI1175429T1/xx unknown
- 2000-05-02 EP EP00920940A patent/EP1175429B1/en not_active Expired - Lifetime
-
2001
- 2001-10-16 ZA ZA200108484A patent/ZA200108484B/xx unknown
- 2001-10-17 IL IL145986A patent/IL145986A/en unknown
- 2001-10-19 IS IS6115A patent/IS6115A/is unknown
- 2001-11-01 NO NO20015346A patent/NO320138B1/no unknown
- 2001-12-03 BG BG106173A patent/BG106173A/bg unknown
-
2002
- 2002-09-26 HK HK02107027.0A patent/HK1045522B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT96145A (pt) | Processo para a preparacao de novos derivados de aminoacidos e de composicoes farmaceuticas que os contem | |
BR0108871A (pt) | Composto, processo de preparação de compostos, e, composição farmacêutica | |
BR9908275A (pt) | Inibidores de enzimas fosfolipase | |
BR0108893A (pt) | Composição farmacêutica, composto e processo de preparação de compostos | |
BRPI9810519A (pt) | derivados de 4''-substituído-9-desoxo-9a-aza-9a-homoeritromicina a e composição farmacêutica compreendendo os mesmos. | |
BR9812653A (pt) | Derivados de carboxamidotiazóis, sua preparação, as composições farmacêuticas que os contêm | |
BR9916633A (pt) | Benzopiranos e benzoxepinas, composições farmacêuticas compreendendo-as e processo de preparação | |
BR9915132A (pt) | Método para inibir a atividade de quinase de proteìna, compostos da fórmula i e sais farmaceuticamente aceitáveis dos mesmos, uso do mesmo, e, composição farmacêutica. | |
BR0013771A (pt) | Composto, métodos de tratamento de uma infecção viral em um mamìfero, de inibir a transcriptase reversa do hiv, e de prevenção da infecção do hiv ou de tratar a infecção do hiv, uso de um composto, e, composição farmacêutica | |
BR9905089A (pt) | Derivados macrolìdeos | |
BR9909468A (pt) | Composto anti-bacteriano, composição oral anti-placas, e, processo para promoção da higiene oral | |
BR9813319A (pt) | Composto, composição farmacêutica para tratamento de infecções bacterianas, e, processos para tratar infecções bacterianas e para preparar um composto | |
BR9812148A (pt) | Derivados de eritromicina 6,9-ligados em ponte | |
BR0010231A (pt) | Derivados de halo de 9a-n-(n'-larilcarbamoil)- e 9a-n-(n'l- ariltiocarbamoil)-9-desoxo-9a-aza-9a-homoeritromici na a | |
BRPI0512951A (pt) | compostos, processo para sua fabricação, composições farmacêuticas contendo os mesmos, uso e método para tratamento e/ou prevenção de doenças que são moduladas pelos agonistas de ppar(delta) e/ou ppar(alpha) | |
BR9705456A (pt) | Compostos heterocìclicos, processo de aminometila para sua preparação e composições farmacêuticas que os contêm. | |
BR0006301A (pt) | Macrólidos antibacterianos e pró-cinéticos | |
BR0106248A (pt) | Inibidores de metaloprotease, processo para a sua preparação e composições farmacêuticas contendo os mesmos | |
BR0008479A (pt) | Agonistas de 5-ht 1f | |
BR0316876A (pt) | Compostos de tiazol e composição farmacêutica compreendendo o mesmo | |
BR0002679A (pt) | Compostos de carboxilato de 7-oxo-2,3,7,14, tetraidro-1h-benzo[b]-pirano[3,2-h]acridina, processo para a sua preparação e composições farmacêuticas contendo os mesmos | |
BR9713587A (pt) | Derivados de ácido 4-(1-piperazinil) benzóico, processo para preparação dos mesmos e suas aplicações terapêuticas | |
BR9900850A (pt) | Novos compostos benzociclobutano, um processo para sua preparação e composições farmacêuticas contendo os mesmos.. | |
BRPI0404006A (pt) | Compostos de benzoindolina, processo para sua preparação e composições farmacêuticas contendo os mesmos | |
ATE234320T1 (de) | Beta,beta-disubstituierte derivate von 9-deoxo-9a-n-ethenyl-9a-aza-9a-homoerythromycin a |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A E 11A ANUIDADE(S). |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2108 DE 31/05/2011. |